VHT Among Health Care ETFs
End-of-day Nov 11, 2026 · 39 Health care ETFs by 1W
Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.2% | +2.4% | +8.8% | +10.5% | +22.4% | +30.0% | +57.7% | +44.1% | +736.1% |
| Peer average | 0.0% | +2.0% | +6.5% | +5.2% | +23.3% | +33.2% | +72.4% | +28.6% | — |
| S&P 500 · VOO | −0.3% | −0.6% | −3.6% | −2.7% | +10.9% | +13.1% | +79.3% | +74.2% | — |
$129 of every $1,000 in VHT is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 12.93% | $1,292.99 | 2.4M | $2.83B |
| 2 | JNJJohnson & Johnson | Healthcare | 8.78% | $877.55 | 7.3M | $1.92B |
| 3 | ABBVAbbVie | Healthcare | 6.45% | $645.19 | 5.4M | $1.41B |
| 4 | MRKMerck | Healthcare | 5.01% | $501.01 | 7.5M | $1.10B |
| 5 | UNHUnitedHealth Group | Healthcare | 4.65% | $465.37 | 2.8M | $1.02B |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.50% | $350.21 | 1.1M | $766.6M |
| 7 | AMGNAmgen | Healthcare | 3.18% | $317.58 | 1.6M | $695.2M |
| 8 | GILDGilead Sciences | Healthcare | 2.58% | $258.34 | 3.8M | $565.5M |
| 9 | ABTAbbott Laboratories | Healthcare | 2.40% | $240.31 | 5.3M | $526.0M |
| 10 | PFEPfizer | Healthcare | 2.27% | $226.91 | 17.4M | $496.7M |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.01% | $201.04 | 1.1M | $440.1M |
| 12 | DHRDanaher | Healthcare | 1.97% | $197.01 | 1.9M | $431.3M |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 1.85% | $185.24 | 776K | $405.5M |
| 14 | BMYBristol-Myers Squibb | Healthcare | 1.78% | $177.88 | 6.2M | $389.4M |
| 15 | MDTMedtronic | Healthcare | 1.54% | $154.20 | 3.9M | $337.5M |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 12.93% |
| 2 | JNJ | Johnson & Johnson | 8.78% |
| 3 | ABBV | AbbVie | 6.45% |
| 4 | MRK | Merck & | 5.01% |
| 5 | UNH | UnitedHealth Group | 4.65% |
| 6 | TMO | Thermo Fisher Scientific | 3.50% |
| 7 | AMGN | Amgen | 3.18% |
| 8 | GILD | Gilead Sciences | 2.58% |
| 9 | ABT | Abbott Laboratories | 2.40% |
| 10 | PFE | Pfizer | 2.27% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 25, 2026 | $0.97 |
| Jun 24, 2026 | Jun 26, 2026 | $0.99 |
| Mar 24, 2026 | Mar 26, 2026 | $0.99 |
| Dec 17, 2025 | Dec 19, 2025 | $1.67 |
| Sep 24, 2025 | Sep 26, 2025 | $1.08 |
| Jun 26, 2025 | Jun 30, 2025 | $0.96 |
| Mar 25, 2025 | Mar 27, 2025 | $0.94 |
| Dec 18, 2024 | Dec 20, 2024 | $0.92 |
| Sep 27, 2024 | Oct 1, 2024 | $1.17 |
| Jun 28, 2024 | Jul 2, 2024 | $0.97 |
| Mar 22, 2024 | Mar 27, 2024 | $0.82 |
| Dec 19, 2023 | Dec 22, 2023 | $0.89 |